Live Breaking News & Updates on Luca Scavo

Stay updated with breaking news from Luca scavo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cytovia Therapeutics appoints CFO, chief product officer

Cytovia Therapeutics, a Florida company with research-and-development operations in Natick, has named a chief financial officer and a chief product officer, as the company advances towards clinical trials and prepares to go public. ....

United States , New Zealand , James Priour , Luca Scavo , Evelo Biosciences Inc , Zymeworks Inc , Business School , Cytovia Therapeutics , Instituto De Empresa , Cambridge Based Evelo Biosciences , Roche Diagnostics North America , Astrazeneca Spain , Southern California ,

Evelo Biosciences, Inc.: Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights


Evelo Biosciences, Inc.: Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights
-Presented further positive data from Phase 1b clinical trial of EDP1815 at International Society of Atopic Dermatitis Meeting-
-Strengthened leadership team with appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to Board of Directors-
-Announced strategic collaboration with Abdul Latif Jameel Health to develop and commercialize EDP1815 in select developing markets-
-Multiple clinical data readouts expected over next 18 months-
-Management to host conference call at 8:30 a.m. ET-
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today reported financial results and business highlights for the first quarter 2021. ....

United Kingdom , Evelo Biosciences , Jessica Cotrone , Julieh Mchugh , Kostenloser Wertpapierhandel , Abdul Latif Jameel , Luca Scavo , Evelo Biosciences Inc , Data Monitoring Committee , Development Expenses , Evelo Leadership Team , International Society Of Atopic Dermatitis , Abdul Latif Jameel Health , International Society , Atopic Dermatitis , Chief Financial Officer , Simba Gill , Chief Executive Officer , Middle East , Hybrid Meeting , Investigator Global Assessment , Eczema Area , Severity Index , Body Surface Area , Independent Data Monitoring Committee , Administrative Expenses ,

Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights
Evelo Biosciences, Inc.April 29, 2021 GMT
–Presented further positive data from Phase 1b clinical trial of EDP1815 at International Society of Atopic Dermatitis Meeting–
–Strengthened leadership team with appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to Board of Directors–
–Announced strategic collaboration with Abdul Latif Jameel Health to develop and commercialize EDP1815 in select developing markets–
–Multiple clinical data readouts expected over next 18 months–
–Management to host conference call at 8:30 a.m. ET– ....

United Kingdom , Evelo Biosciences , Jessica Cotrone , Julieh Mchugh , Abdul Latif Jameel , Luca Scavo , Evelo Biosciences Inc , Data Monitoring Committee , Development Expenses , Evelo Leadership Team , International Society Of Atopic Dermatitis , Abdul Latif Jameel Health , International Society Of Atopic Dermatitis Meeting , International Society , Atopic Dermatitis Meeting , Chief Financial Officer , Simba Gill , Chief Executive Officer , Middle East , Atopic Dermatitis , Hybrid Meeting , Investigator Global Assessment , Eczema Area , Severity Index , Body Surface Area , Independent Data Monitoring Committee ,

Evelo Biosciences, Inc. (EVLO) Q1 2021 Earnings Call Transcript


Evelo Biosciences, Inc. (EVLO) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Evelo Biosciences, Inc. (NASDAQ: EVLO)
Q1 2021 Earnings Call
Good morning, and welcome to Evelo Biosciences conference call to discuss the first-quarter 2021 financial results and business highlights. [Operator instructions] Please be advised that this call is being recorded at the company s request. At this time, I d like to turn the call over to Jessica Cotrone of Evelo. Please proceed.
Jessica Cotrone
Vice President, Head of of Communications
Thank you. This morning we issued the press release that outlines the topics we plan to discuss today. This release is available at www.evelobio.com under the investors tab. Today in our call, we have Simba Gill, chief executive officer; Mark Bodmer, president of R&D and chief scientific officer; and Jonathan Zung, chief development ....

United States , United Kingdom , Evelo Biosciences , Jonathan Zung , Matthew Harrison Morgan Stanley , Joe Thome Cowen , Abdul Latif Jameel , Joe Thome , Kechun Zhang , Jessica Cotrone , Matthew Harrison , Mark Bodmer , Matthew Luchini , Julie Mchugh , Luca Scavo , Morgan Stanley , Evelo Biosciences Inc , Data Monitoring Committee , Rutgers Robert Wood Johnson University Hospital , Motley Fool Evelo Biosciences Inc , Exchange Commission , Cambridge University Hospitals , Company Analyst , Abdul Latif Jameel Health , Motley Fool Evelo Biosciences , Call Transcript ,